These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 26755660)
1. Hypoxia-induced lncRNA-NUTF2P3-001 contributes to tumorigenesis of pancreatic cancer by derepressing the miR-3923/KRAS pathway. Li X; Deng SJ; Zhu S; Jin Y; Cui SP; Chen JY; Xiang C; Li QY; He C; Zhao SF; Chen HY; Niu Y; Liu Y; Deng SC; Wang CY; Zhao G Oncotarget; 2016 Feb; 7(5):6000-14. PubMed ID: 26755660 [TBL] [Abstract][Full Text] [Related]
2. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Zeng Z; Xu FY; Zheng H; Cheng P; Chen QY; Ye Z; Zhong JX; Deng SJ; Liu ML; Huang K; Li Q; Li W; Hu YH; Wang F; Wang CY; Zhao G Theranostics; 2019; 9(18):5298-5314. PubMed ID: 31410216 [No Abstract] [Full Text] [Related]
3. MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Niu Y; Jin Y; Deng SC; Deng SJ; Zhu S; Liu Y; Li X; He C; Liu ML; Zeng Z; Chen HY; Zhong JX; Ye Z; Wang CY; Zhao G Oncogene; 2018 Mar; 37(13):1743-1758. PubMed ID: 29343850 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced feedback of HIF-1α and lncRNA-CF129 contributes to pancreatic cancer progression through stabilization of p53 protein. Liu M; Zhong J; Zeng Z; Huang K; Ye Z; Deng S; Chen H; Xu F; Li Q; Zhao G Theranostics; 2019; 9(16):4795-4810. PubMed ID: 31367258 [No Abstract] [Full Text] [Related]
5. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Deng SJ; Chen HY; Ye Z; Deng SC; Zhu S; Zeng Z; He C; Liu ML; Huang K; Zhong JX; Xu FY; Li Q; Liu Y; Wang CY; Zhao G Oncogene; 2018 Nov; 37(44):5811-5828. PubMed ID: 29970904 [TBL] [Abstract][Full Text] [Related]
6. MiR-143-3p suppresses tumorigenesis in pancreatic ductal adenocarcinoma by targeting KRAS. Xie F; Li C; Zhang X; Peng W; Wen T Biomed Pharmacother; 2019 Nov; 119():109424. PubMed ID: 31521891 [TBL] [Abstract][Full Text] [Related]
7. MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. Zhu S; He C; Deng S; Li X; Cui S; Zeng Z; Liu M; Zhao S; Chen J; Jin Y; Chen H; Deng S; Liu Y; Wang C; Zhao G Mol Cancer Ther; 2016 Sep; 15(9):2209-19. PubMed ID: 27353169 [TBL] [Abstract][Full Text] [Related]
8. Long Non-coding RNA LINC01420 Contributes to Pancreatic Cancer Progression Through Targeting KRAS Proto-oncogene. Zhai H; Zhang X; Sun X; Zhang D; Ma S Dig Dis Sci; 2020 Apr; 65(4):1042-1052. PubMed ID: 31562613 [TBL] [Abstract][Full Text] [Related]
9. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96. Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400 [TBL] [Abstract][Full Text] [Related]
11. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α. Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145 [TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972 [TBL] [Abstract][Full Text] [Related]
13. LncRNA ZNFTR functions as an inhibitor in pancreatic cancer by modulating ATF3/ZNF24/VEGFA pathway. Li W; Han S; Hu P; Chen D; Zeng Z; Hu Y; Xu F; Tang J; Wang F; Zhao Y; Huang M; Zhao G Cell Death Dis; 2021 Sep; 12(9):830. PubMed ID: 34480024 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446 [TBL] [Abstract][Full Text] [Related]
15. LncRNA XIST Promotes Pancreatic Cancer Proliferation Through miR-133a/EGFR. Wei W; Liu Y; Lu Y; Yang B; Tang L J Cell Biochem; 2017 Oct; 118(10):3349-3358. PubMed ID: 28295543 [TBL] [Abstract][Full Text] [Related]
16. Establishment of a non‑coding RNAomics screening platform for the regulation of KRAS in pancreatic cancer by RNA sequencing. Zhang L; Yu S; Wang C; Jia C; Lu Z; Chen J Int J Oncol; 2018 Dec; 53(6):2659-2670. PubMed ID: 30221677 [TBL] [Abstract][Full Text] [Related]
17. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions. Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528 [TBL] [Abstract][Full Text] [Related]
18. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723 [TBL] [Abstract][Full Text] [Related]
19. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer. Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c. Zhou X; Chen H; Zhu L; Hao B; Zhang W; Hua J; Gu H; Jin W; Zhang G Oncotarget; 2016 Dec; 7(50):82770-82782. PubMed ID: 27835575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]